|
|
H2025/CTD11019/24077
|
LINEMPA 10/5
|
EMPAGLIFLOZIN + LINAGLIPTIN.
|
LABORATORY & ALLIED LTD
|
Registered
|
Details →
|
|
|
H2025/CTD11054/24078
|
LINEMPA 25/5
|
EMPAGLIFLOZIN + LINAGLIPTIN.
|
LABORATORY & ALLIED LTD
|
Registered
|
Details →
|
|
|
H2025/CTD11832/26166
|
EMPAZIN-L 10MG/5MG TABLET
|
EMPAGLIFLOZIN + LINAGLIPTIN
|
GLOBE PHARMACY LTD
|
Registered
|
Details →
|
|
|
H2025/CTD11833/26167
|
EMPAZIN-L 25MG/5MG TABLET
|
EMPAGLIFLOZIN + LINAGLIPTIN
|
GLOBE PHARMACY LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10803/22171
|
EMPIGET-LT TABLETS 10MG+5MG
|
EMPAGLIFLOZIN + LINAGLIPTIN
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD10805/22163
|
EMPIGET-LT TABLETS 25MG+5MG
|
EMPAGLIFLOZIN + LINAGLIPTIN
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2024/CTD9189/17041
|
GLYXAMBI 10 MG / 5 MG TABLETS
|
EMPAGLIFLOZIN + LINAGLIPTIN
|
Boehringer Ingelheim international GmbH
|
Withdrawn Voluntarily by MAH
|
Details →
|
|
|
H2024/CTD9190/17044
|
GLYXAMBI 25 MG / 5 MG TABLETS
|
EMPAGLIFLOZIN + LINAGLIPTIN
|
Boehringer Ingelheim international GmbH
|
Withdrawn Voluntarily by MAH
|
Details →
|